Inventor · disambiguated record
Gerald Beste
Also filed as: BESTE GERALD
18 granted patents·12 pending applications·135 citations·filing 2003–2024
94Inventor score
Top patents by PatentIndex Score
30 records- 0197US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0294US8703135B2Biological materials related to c-MetBESTE GERALD·Filed 2012·Granted Apr 22, 2014·41 cites·26 claims
- 0393US9683045B2Biological materials related to c-MetABLYNX NV·Filed 2014·Granted Jun 20, 2017·17 cites·12 claims
- 0493US9346884B2Biological materials related to c-MetABLYNX NV·Filed 2012·Granted May 24, 2016·15 cites·5 claims
- 0592US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 0692US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 0788US8337845B2A-beta binding polypeptidesPARK JOHN E·Filed 2011·Granted Dec 25, 2012·18 cites·12 claims
- 0885US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 0985US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 1083US12129308B2MMP13 binding immunoglobulinsMERCK PATENT GMBH·Filed 2018·Granted Oct 29, 2024·2 cites·16 claims
- 1181US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 1277US11813307B2Polypeptides binding ADAMTS5, MMP13 and aggrecanMERCK PATENT GMBH·Filed 2018·Granted Nov 14, 2023·2 cites·13 claims
- 1377US10808032B2Biological materials related to HER3ABLYNX NV·Filed 2018·Granted Oct 20, 2020·1 cites·20 claims
- 1476US11603401B2Aggrecan binding immunoglobulinsABLYNX NV·Filed 2018·Granted Mar 14, 2023·2 cites·13 claims
- 1576US2025129183A1Mmp13 binding immunoglobulinsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1675US9932403B2Biological materials related to HER3KNUEHL CHRISTINE·Filed 2011·Granted Apr 3, 2018·3 cites·8 claims
- 1773US11248055B2Polypeptides inhibiting CD40LABLYNX NV·Filed 2016·Granted Feb 15, 2022·2 cites·13 claims
- 1869US2024181006A1Polypeptides binding adamts5, mmp13 and aggrecanMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 1968US8614308B2Nucleic acid molecules encoding A-beta binding polypeptidesPARK JOHN E·Filed 2012·Granted Dec 24, 2013·1 cites·3 claims
- 2066US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 2165US2023312694A1Aggrecan binding immunoglobulinsABLYNX NV·Filed 2022·Application pending·0 cites
- 2265US2025215102A1Cd28/ox40 bispecific antibodiesSANOFI SA·Filed 2024·Application pending·0 cites
- 2364US12195546B2CD28/OX40 bispecific antibodiesSANOFI SA·Filed 2023·Granted Jan 14, 2025·0 cites·26 claims
- 2462US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 2556US9211330B2A-beta binding polypeptidesABLYNX NV·Filed 2013·Granted Dec 15, 2015·0 cites·5 claims
- 2651US2009215175A1Modulation of the poliovirus receptor functionTUFTS COLLEGE·Filed 2008·Application pending·0 cites
- 2749US2007041985A1Modulation of the poliovirus receptor functionUNGER CHRISTINE M·Filed 2004·Application pending·0 cites
- 2848US2006115477A1Neuropilin-1 inhibitorsUNGER CHRISTINE M·Filed 2003·Application pending·0 cites
- 2937US2012058117A1Neuropilin-1 inhibitorsUNGER CHRISTINE MARGARETE·Filed 2011·Application pending·0 cites
- 3030US2011117113A1Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate themBESTE GERALD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gerald Beste files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →